Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APOP

Cellect Biotechnology (APOP) Stock Price, News & Analysis

Cellect Biotechnology logo

About Cellect Biotechnology Stock (NASDAQ:APOP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$7.54
$13.40
52-Week Range
N/A
Volume
17,400 shs
Average Volume
479,845 shs
Market Capitalization
$12.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive APOP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

APOP Stock News Headlines

Did you miss out on Trump’s “birthday gift” to Americans?
While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his actions. This setup is part of a larger pattern — one that repeats whenever Trump makes waves. Now, veteran trader Larry Benedict is revealing three “Trigger Tickers” that could deliver 2–3X returns… plus a $194 trillion catalyst that could light up the markets.
Krystal Biotech Inc.
Raleigh/Durham Biotech News
See More Headlines

APOP Stock Analysis - Frequently Asked Questions

Cellect Biotechnology Ltd. (NASDAQ:APOP) released its earnings results on Tuesday, November, 13th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02.

Cellect Biotechnology's stock split before market open on Tuesday, October 26th 2021.The 2-1 split was announced on Tuesday, October 26th 2021. The newly created shares were payable to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Advanced Micro Devices (AMD), NVIDIA (NVDA), Acasti Pharma (ACST) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
11/13/2018
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APOP
Employees
2,020
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$12.87 million
Optionable
Not Optionable
Beta
1.87

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:APOP) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners